[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.129.96. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
June 1973

A Clinical Evaluation of 0.05% Desonide CreamA New Nonfluorinated Topical Corticosteroid

Author Affiliations

Denver; Memphis; Denver

From Denver General Hospital (Dr. Gentry), the University of Colorado Medical Center (Dr. Goltz), Denver; the University of Tennessee College of Medicine, and the Memphis Veterans Administration Hospital (Dr. Rosenberg).

Drs. Gentry and Goltz are now with the Department of Dermatology, University of Minnesota School of Medicine, Minneapolis.

Arch Dermatol. 1973;107(6):870-871. doi:10.1001/archderm.1973.01620210038010
Abstract

Desonide cream, 0.05%, is a new nonfluorinated topical steroid cream. A doubleblind clinical evaluation of 133 patients demonstrates it to be as effective as 0.025% fluocinolone acetonide cream in the treatment of steroid responsive dermatoses with no statistically significant preponderance for either steroid.

×